Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Trial of Moxifloxacin for Tb
Chaisson, Richard E.
Johns Hopkins University, Baltimore, MD, United States
Search 146 grants from Richard Chaisson
Search grants from Johns Hopkins University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Nuclear receptors and their Coactivators as Mediators of Systems Metabolism
Vascular function, cardiovascular disease biomarkers and the Latino paradox
Refining Estimates of Kidney Function in the U.S.
Phase II Trial of Poly-Iclc for Glioblastoma [Nabtc 01-05]
Molecular Regulation of Neoplastic and Normal Growth
Recently added grants:
Timing Of Exercise In Concussed Rat Athletes
Motor cortical signaling of impedance during manipulation
Astrocyte-specific IL-1RI signaling effects following traumatic brain injury
Advanced Statistical Analytics of MRI in MS
Neuromuscular mechanisms of specific trunk interventions in children with cerebral palsy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Research Project (R01)
Project #
3R01FD002135-03S1
Application #
7448527
Study Section
Special Emphasis Panel (ZFD1-SRC (99))
Program Officer
Ganti, Usha
Project Start
2003-09-30
Project End
2008-04-30
Budget Start
2006-05-01
Budget End
2008-04-30
Support Year
3
Fiscal Year
2007
Total Cost
Indirect Cost
Institution
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Related projects
NIH 2007
R01 FD
Phase II Trial of Moxifloxacin for Tb
Chaisson, Richard E. / Johns Hopkins University
NIH 2006
R01 FD
Phase II Trial of Moxifloxacin for Tb
Chaisson, Richard E. / Johns Hopkins University
Publications
Conde, Marcus B; Efron, Anne; Loredo, Carla et al.
(2009)
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.
Lancet 373:1183-9
Comments
Be the first to comment on Richard Chaisson's grant